Circulation: Cardiovascular Interventions

JANUARY 20, 2025

Circulation: Cardiovascular Interventions, Volume 18, Issue 1 , Page e014592, January 1, 2025. We additionally compared end points across treatment arms using trial-adjudicated outcomes versus claims-based outcomes.RESULTS:Trial-adjudicated deaths were perfectly identified by claims.

Aortic valve 40

Aortic valve Outcomes Pacemaker Aortic 40

Circulation: Cardiovascular Quality & Outcomes

OCTOBER 19, 2023

Circulation: Cardiovascular Quality and Outcomes, Volume 16, Issue 11 , Page e010148, November 1, 2023. BACKGROUND:Although disparities in cardiac rehabilitation (CR) participation are well documented, the role of community-level distress is poorly understood.

Cardiac Rehabilitation 40

Cardiac Rehabilitation Inpatient Myocardial Infarction Outcomes 40

Circulation

NOVEMBER 11, 2024

Circulation, Volume 150, Issue Suppl_1 , Page A4142159-A4142159, November 12, 2024. While TR can worsen the clinical outcomes in HF patients, its impact on gender, racial and socioeconomic factors remains largely unexplored.

Heart Failure 40

Heart Failure Tricuspid Outcomes Medicare 40

American College of Cardiology

FEBRUARY 1, 2025

Cardiovascular medications frequently lead this category, often contributing to adverse clinical outcomes, including emergency department visits and hospitalizations. Circulation. Circulation. The good news is that these metrics are evolving to better meet the unique needs of older, frail patients. BMC Med2015;13(74).

Cardiovascular Disease 40

Cardiovascular Disease Coronary Artery Disease CMS Hospital 40

DAIC

MAY 16, 2024

A new joint guideline from the American Heart Association (AHA), the American College of Cardiology (ACC) and nine other medical societies reports early diagnosis and treatment of peripheral artery disease is essential to improve outcomes and reduce amputation risk, heart attack, stroke and death for people with Peripheral Artery Disease (PAD).

Peripheral Arterial Disease 105

Peripheral Arterial Disease Exercise Ischemia Quality of Life 105

Circulation: Cardiovascular Quality & Outcomes

JANUARY 19, 2024

Circulation: Cardiovascular Quality and Outcomes, Ahead of Print. Background:Type 2 myocardial infarction (T2MI) and type 1 myocardial infarction (T1MI) differ with respect to demographics, comorbidities, treatments, and clinical outcomes.

Myocardial Infarction 40

Myocardial Infarction COVID-19 Medicare Hospital 40

Circulation: Cardiovascular Quality & Outcomes

MARCH 3, 2025

Circulation: Cardiovascular Quality and Outcomes, Ahead of Print. The Cox proportional hazards model was used to estimate hazard ratios of outcomes with 95% CIs.RESULTS:In cohort 1, we identified 1159 and 3477 patients in the pLAAO and direct oral anticoagulant groups with a mean age of 78.1 versus 40.8% versus 8.97/100

Atrial Fibrillation 40

Atrial Fibrillation Medicare Outpatient Cancer 40

Cardiomatics

FEBRUARY 9, 2022

Bundle-Branch Block Morphology and Other Predictors of Outcome After Cardiac Resynchronization Therapy in Medicare Patients. Circulation 2010, 122, 2022–2030. [6] Long-term mortality with cardiac resynchronization therapy in the Cardiac Resynchronization-Heart Failure (CARE-HF) trial. Heart Fail. 2012, 14, 628–634. [5]

Heart Failure 52

Heart Failure Myocardial Infarction Medicare Defibrillator 52

Circulation

NOVEMBER 11, 2024

Circulation, Volume 150, Issue Suppl_1 , Page A4141439-A4141439, November 12, 2024. The outcome follow-up began after the 6-month period. Background:Catheter ablation (CA) is increasingly used for treatment of atrial fibrillation (AF). However, CA has not been widely adopted in the older population with AF.

Atrial Fibrillation 40

Atrial Fibrillation Medicare Ablation Outcomes 40

Circulation: Cardiovascular Quality & Outcomes

APRIL 3, 2025

Circulation: Cardiovascular Quality and Outcomes, Ahead of Print. We evaluated trends in stroke and death among Medicare beneficiaries with AF between 2013 and 2019.METHODS:Medicare METHODS:Medicare fee-for-service beneficiaries >65 years old (20112019) were included. per 1000 patient-years).

Medicare 40

Medicare Atrial Fibrillation Strokes Stroke 40

Society of Thoracic Surgeons - Research

APRIL 20, 2023

Adult Cardiac Surgery Database Lead Author Title Publication Date Jacob Raphael Red Blood Cell Transfusion and Pulmonary Complications: The Society of Thoracic Surgeons Adult Cardiac Surgery Database Analysis The Annals of Thoracic Surgery January 2024 Joseph Sabik Multi-Arterial versus Single-Arterial Coronary Surgery: Ten Year Follow-up of One Million (..)

Research 52

Research Coronary Artery Bypass Graft Aortic valve Congenital 52

Society of Thoracic Surgeons - Research

APRIL 20, 2023

Program Designations Access and Publications (A&P) 1 Participant User File (PUF) 2 Task Force on Funded Research (TFR) 3 Special Projects 4 Adult Cardiac Surgery Database Lead Author Title Publication Date William Keeling 2 National Trends in Emergency Coronary Artery Bypass Grafting European Journal of Cardiothoracic Surgery October 2023 Jake (..)

Research 52

Research Coronary Artery Bypass Graft Aortic valve Congenital 52

Circulation: Heart Failure

JANUARY 26, 2024

Circulation: Heart Failure, Ahead of Print. CONCLUSIONS:Bariatric surgery and pharmacotherapies with weight loss effects are associated with a lower risk of adverse outcomes among older patients with HF and obesity; however, overall utilization remains low. In propensity-matched analysis over a median follow-up of 2.8 0.99];P=0.04).CONCLUSIONS:Bariatric

Heart Failure 40

Heart Failure Obesity Outcomes Medicare 40

Circulation: Cardiovascular Quality & Outcomes

DECEMBER 12, 2023

Circulation: Cardiovascular Quality and Outcomes, Ahead of Print. METHODS:Using Medicare-linked data from the Evolut Low Risk trial, we identified 619 patients: 606 (322 TAVR/284 SAVR) and 593 (312 TAVR/281 SAVR) were analyzed at 1 and 2 years, respectively. Secondary outcomes DAH30and DAH90were higher in TAVR (DAH30, 26.0±3.6

Aortic valve 40

Aortic valve TAVR Aortic Medicare 40

Circulation: Cardiovascular Quality & Outcomes

JANUARY 8, 2024

Circulation: Cardiovascular Quality and Outcomes, Ahead of Print. The primary outcome was referral to community-based rehabilitation (physical, occupational, or speech therapy) at discharge. 2.44]), and having Medicare insurance (1.12 [1.02–1.23]) Female sex (odds ratio, 1.24 [95% CI, 1.12–1.38]),

Strokes 40

Strokes Stroke Hospital Medicare 40

Circulation: Cardiovascular Quality & Outcomes

MARCH 5, 2024

Circulation: Cardiovascular Quality and Outcomes, Ahead of Print. BACKGROUND:Transcatheter left atrial appendage occlusion (LAAO) is an alternative to oral anticoagulants (OACs) for stroke prevention in patients with atrial fibrillation, but the predictors of LAAO use in routine care are unclear.

Atrial Fibrillation 40

Atrial Fibrillation Medicaid Cancer Medicare 40

Circulation

JANUARY 23, 2024

Circulation, Ahead of Print. The primary outcome was the use of optimal GDMT within 12 months of HFrEF diagnosis. 0.76]) compared with Medicare (HR, 0.85 [95% CI, 0.77–0.92]);Pinteractionsex×insurance 0.92]);Pinteractionsex×insurance status=0.005) and for younger patients (age <65 years: HR, 0.65 [95% CI, 0.58–0.74])

Heart Failure 45

Heart Failure Medicare Circulation Outcomes 45